7.85
-0.07
(-0.83%)
As of 8:09:48 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DONHAUSER PETER D.O. Director | Purchase | Jun 14, 2024 | 5,000 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security | Mar 24, 2025 | 1,467,710 |
| THOMAS STEFFEN PHD Director | Purchase | May 15, 2024 | 5,000 |
Related Tickers
RXK3.MU SELLAS Life Sciences Group Inc
1.1170
+6.69%
SAVA.MX Cassava Sciences, Inc.
57.20
+0.12%
I9SA.HA Verona Pharma PLC
50.00
-3.47%
IPSC Century Therapeutics, Inc.
0.4751
-5.17%
IVVD Invivyd, Inc.
0.4820
-6.23%
ANVS Annovis Bio, Inc.
1.2595
+3.24%
CRDF Cardiff Oncology, Inc.
2.9950
+1.87%
CYTK Cytokinetics, Incorporated
38.42
-0.38%
SANA Sana Biotechnology, Inc.
1.6250
-4.41%
GPCR Structure Therapeutics Inc.
18.46
-2.35%